• Home
  • Study Details
Open

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Phase II/III research study to determine how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Extended hours (M-F, early morning or evening)

Location

North Carolina (Statewide)

What will be asked of you

At each visit, you will meet with a member of the study team to discuss your treatment or follow-up on previous treatment. The study also involves a blood draw, Multiple FDG PET/CT scans, and the use of oral CT contrast material.

In-person visits:
Around 15
Total length of participation:
About 5 years

Looking for Specific Volunteers

Able to participate:

  • You have a pathologically (histologically or cytologically) proven diagnosis of squamous cell carcinoma of the oral cavity
  • You are age ≥ 18
  • For women of child bearing potential: you must have a negative serum or urine pregnancy test within 42 days prior to registration
  • You are able to read and understand English
  • You have had a surgical assessment within 42 days prior to registration.

Not eligible if:

  • You have definitive clinical or radiologic evidence of regional (cervical) and/or distant metastatic disease;
  • You have prior non-head and neck invasive malignancy
  • You have diagnosis of head and neck SCC in the oropharynx, nasopharynx, hypopharynx, or larynx
  • You have received prior systemic chemotherapy for the study cancer; note that prior chemotherapy for a different cancer is allowable.
  • You are currently participating in another investigational therapeutic trial

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Trevor Hackman
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Head and Neck)

IRB Number

23-1131

ClinicalTrials.gov

NCT04333537

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research